FR2342061B1 - - Google Patents

Info

Publication number
FR2342061B1
FR2342061B1 FR7705295A FR7705295A FR2342061B1 FR 2342061 B1 FR2342061 B1 FR 2342061B1 FR 7705295 A FR7705295 A FR 7705295A FR 7705295 A FR7705295 A FR 7705295A FR 2342061 B1 FR2342061 B1 FR 2342061B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7705295A
Other versions
FR2342061A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2342061A1 publication Critical patent/FR2342061A1/fr
Application granted granted Critical
Publication of FR2342061B1 publication Critical patent/FR2342061B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7705295A 1976-02-24 1977-02-23 Formulations pour application topique de steroides Granted FR2342061A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/660,963 US4048310A (en) 1976-02-24 1976-02-24 Topical steroid formulation in form of lotion or cream

Publications (2)

Publication Number Publication Date
FR2342061A1 FR2342061A1 (fr) 1977-09-23
FR2342061B1 true FR2342061B1 (fr) 1981-06-26

Family

ID=24651635

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705295A Granted FR2342061A1 (fr) 1976-02-24 1977-02-23 Formulations pour application topique de steroides

Country Status (5)

Country Link
US (1) US4048310A (fr)
AU (1) AU507804B2 (fr)
CA (1) CA1085725A (fr)
FR (1) FR2342061A1 (fr)
GB (1) GB1578072A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137311A (en) * 1977-09-22 1979-01-30 William H. Rorer, Inc. Synergistic compositions and method of use
US4233295A (en) * 1979-05-31 1980-11-11 E. R. Squibb & Sons, Inc. Corticosteroid formulations containing sebacate carrier
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
US5635497A (en) * 1982-06-23 1997-06-03 Yamanouchi Europe B.V. Topical application compositions
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4868168A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid ointment formulation
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
CA2112751A1 (fr) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition et methode pour l'injection transdermique de diclofenac
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
WO2006031848A2 (fr) * 2004-09-15 2006-03-23 Ivax Corporation Corticosteroide ayant une faible absorption systemique
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
TWI705831B (zh) 2015-05-21 2020-10-01 瑞士商德瑪凡特科學有限公司 局部醫藥組成物
US11617724B2 (en) * 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
WO2016205001A1 (fr) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Compositions topiques comprenant un corticostéroïde et un rétinoïde pour le traitement du psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
US3892856A (en) * 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3971772A (en) * 1975-01-06 1976-07-27 E. R. Squibb & Sons, Inc. Steroidal[16α,17-b]1,4-dioxanes and Steroidal[16α,17-b]1,4-dioxins

Also Published As

Publication number Publication date
CA1085725A (fr) 1980-09-16
AU507804B2 (en) 1980-02-28
US4048310A (en) 1977-09-13
FR2342061A1 (fr) 1977-09-23
AU2236677A (en) 1978-08-24
GB1578072A (en) 1980-10-29

Similar Documents

Publication Publication Date Title
CH637798GA3 (fr)
JPS5628078Y2 (fr)
FR2342225B1 (fr)
CS177447B1 (fr)
CS177441B1 (fr)
CS175528B1 (fr)
CH604053A5 (fr)
CH611991A5 (fr)
CH603335A5 (fr)
CH603378A5 (fr)
CH603553A5 (fr)
CH603984A5 (fr)
CH603197A5 (fr)
CH604280A5 (fr)
CH604847A5 (fr)
CH604860A5 (fr)
CH605211A5 (fr)
CH606833A5 (fr)
CH606873A5 (fr)
CH607232A5 (fr)
CH608051A5 (fr)
CH609151A5 (fr)
CH609471A5 (fr)
CH610400A5 (fr)
CH610575A5 (fr)